Literature DB >> 21212509

Effects of chemical modification of ursodeoxycholic acid on TGR5 activation.

Yusuke Iguchi1, Tomoko Nishimaki-Mogami, Masafumi Yamaguchi, Fumiteru Teraoka, Tetsuo Kaneko, Mizuho Une.   

Abstract

The aim of this study is to examine the ability of the bile acid analogues obtained by chemical modification of ursodeoxycholic acid (UDCA) for TGR5 activation. Eleven UDCA analogues including 3- or 7-methylated UDCAs and amino acid conjugates were investigated as to their ability to activate TGR5 by means of the luciferase assay. It was noteworthy that 7α-methylated UDCA, namely 3α,7β-dihydroxy-7α-methyl-5β-cholanoic acid, had a significantly high affinity for and ability to activate TGR5 as compared to UDCA. Additionally, FXR activation ability of 7α-methylated UDCA was low relative to that of UDCA. However, other modification of UDCA, such as the introduction of methyl group at its C-3 position and oxidation or epimerization of hydroxyl group in the C-3 position, could not elicit such remarkable effect. The present findings would provide a useful strategy for the development of TGR5-selective agonist.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212509     DOI: 10.1248/bpb.34.1

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.

Authors:  Stephen J Keely; Andreacarola Urso; Alexandr V Ilyaskin; Christoph Korbmacher; Nigel W Bunnett; Daniel P Poole; Simona E Carbone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-10       Impact factor: 4.052

2.  Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.

Authors:  Jung Seok Lee; Patrick Han; Rabib Chaudhury; Shihan Khan; Sean Bickerton; Michael D McHugh; Hyun Bong Park; Alyssa L Siefert; Gerald Rea; José M Carballido; David A Horwitz; Jason Criscione; Karlo Perica; Robert Samstein; Ragy Ragheb; Dongin Kim; Tarek M Fahmy
Journal:  Nat Biomed Eng       Date:  2021-10-06       Impact factor: 25.671

3.  The TGR5 receptor mediates bile acid-induced itch and analgesia.

Authors:  Farzad Alemi; Edwin Kwon; Daniel P Poole; TinaMarie Lieu; Victoria Lyo; Fiore Cattaruzza; Ferda Cevikbas; Martin Steinhoff; Romina Nassini; Serena Materazzi; Raquel Guerrero-Alba; Eduardo Valdez-Morales; Graeme S Cottrell; Kristina Schoonjans; Pierangelo Geppetti; Stephen J Vanner; Nigel W Bunnett; Carlos U Corvera
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

4.  Fibroblast growth factor 21 correlates with weight loss after vertical sleeve gastrectomy in adolescents.

Authors:  Farooq H Khan; Lindsey Shaw; Wujuan Zhang; Rosa Maria Salazar Gonzalez; Sarah Mowery; Melissa Oehrle; Xueheng Zhao; Todd Jenkins; Kenneth D R Setchell; Thomas H Inge; Rohit Kohli
Journal:  Obesity (Silver Spring)       Date:  2016-09-12       Impact factor: 5.002

5.  Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.

Authors:  Henri Duboc; Ganna Tolstanova; Pu-Qing Yuan; Vincent Wu; Izumi Kaji; Mandy Biraud; Yasutada Akiba; Jonathan Kaunitz; Mulugeta Million; Yvette Tache; Muriel Larauche
Journal:  Neurogastroenterol Motil       Date:  2016-06-03       Impact factor: 3.598

6.  Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes.

Authors:  Lucia Mališová; Zuzana Kováčová; Michal Koc; Jana Kračmerová; Vladimír Stich; Lenka Rossmeislová
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

7.  Ursodeoxycholic Acid Halts Pathological Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.

Authors:  Menaka C Thounaojam; Ravirajsinh N Jadeja; Shubhra Rajpurohit; Diana R Gutsaeva; Brian K Stansfield; Pamela M Martin; Manuela Bartoli
Journal:  J Clin Med       Date:  2020-06-19       Impact factor: 4.241

8.  Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5.

Authors:  Youchao Qi; Linkai Shi; Guozhen Duan; Yonggui Ma; Peifeng Li
Journal:  Molecules       Date:  2021-11-23       Impact factor: 4.411

Review 9.  The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?

Authors:  Youchao Qi; Guozhen Duan; Dengbang Wei; Chengzhou Zhao; Yonggui Ma
Journal:  Molecules       Date:  2022-08-19       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.